A Double-Blind, Placebo-Controlled, Enriched Enrollment Randomized Withdrawal Study to Evaluate the Efficacy of Milnacipran in the Treatment of Pain Due to Osteoarthritis.
Phase of Trial: Phase IV
Latest Information Update: 27 Feb 2017
At a glance
- Drugs Milnacipran (Primary)
- Indications Musculoskeletal pain; Osteoarthritis
- Focus Therapeutic Use
- 16 Aug 2011 Status changed from not yet recruiting to recruiting as reported by ClinicalTrials.gov.
- 16 Jun 2011 Planned initiation date changed from 1 Apr 2011 to 1 Jul 2011 as reported by ClinicalTrials.gov.
- 08 Apr 2011 New trial record